Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
06/1998
06/04/1998WO1998023282A1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
06/04/1998WO1998023279A1 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND
06/04/1998WO1998023273A1 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators
06/04/1998WO1998023267A1 Use of hydroxyguanidines
06/04/1998WO1998023244A2 Intracoronary stents containing quinazolinone derivatives
06/04/1998WO1998009948A3 Nitric ester derivatives and their use in urinary incontinence and other diseases
06/04/1998CA2272932A1 Use of hydroxyguanidines
06/04/1998CA2272683A1 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998CA2272644A1 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998CA2272565A1 Integrin receptor antagonists
06/04/1998CA2272388A1 Benzamidoaldehydes and their use as cysteine protease inhibitors
06/04/1998CA2272243A1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
06/04/1998CA2271689A1 Radiolabeled dna oligonucleotide, method of preparation and therapeutic uses thereof
06/04/1998CA2266605A1 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators
06/04/1998CA2223541A1 New imidazoline derivatives, preparation process and the pharmaceutical compositions containing them
06/04/1998CA2223366A1 3-hydroxypyridine-2-carboxamidoesters, their preparation and their use as pharmaceuticals
06/03/1998EP0845535A2 Leader peptidase (lep) from Streptococcus
06/03/1998EP0845269A2 Liposomal human calcitonin gene-related peptide composition and preparation of the same
06/03/1998EP0845265A1 Mucosal preparation containing physiologically active peptide
06/03/1998EP0845035A2 Urocortin peptides
06/03/1998EP0844877A1 Use of oxido-squalene cyclase inhibitors to lower blood cholesterol
06/03/1998EP0844874A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF $g(a) v?$g(b) 5? MEDIATED ANGIOGENESIS
06/03/1998CN1183786A Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition
06/03/1998CN1183765A Phenoxyethyamine derivs. having high affinity for 5 -HT1A receptor, preparation thereof, use thereof as drugs, and pharmaceutical composition contg. said derivs
06/03/1998CN1183763A Tetralines bearing phenyl substituant on aromatic ring and their use in treatment of epilepsy, stroke and brain or spinal trauma
06/03/1998CN1183413A Thiazolidine derivative and its use for making medicanients
06/03/1998CN1183281A Ointment contg. low-molecular heparin and its preparing method
06/03/1998CN1183276A Pharmaceutical compositions containing thiazolidine derivative and preparation process thereof
06/03/1998CN1183275A Use of thiazolidine derivative for making medicaments
06/03/1998CN1038587C Process for preparation of 1, 4 -dihydropyridine derivs.
06/03/1998CN1038586C Process for preparing pyrazine derivs
06/03/1998CN1038585C Process for preparation of 2, 4 - and 2, 5 -substd. pyridine -N -oxides
06/03/1998CN1038582C Benzene deriv. useful for ischemic diseases
06/02/1998US5760276 Aryl-and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity
06/02/1998US5760248 Having improved metabolic stability
06/02/1998US5760241 Thiol derivatives with metallopeptidase inhibitory activity
06/02/1998US5760180 Kits and dna(cdna) codes and cloning expression vectors
06/02/1998US5760087 Glycylanilide derivatives, their preparation and their application in therapy
06/02/1998US5760074 Central nervous system disorders
06/02/1998US5760073 Treatment of central nervous system disorders
06/02/1998US5760068 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
06/02/1998US5760057 Anticoagulants
06/02/1998US5760038 Substituted biphenyl sulfonamide endothelin antagonists
06/02/1998US5760037 Derivatives of N'N'-di(aralkyl)-N,N'-di(2-azaaralkyl)alkylene diamine and the use thereof in pharmaceutical and cosmetic compostions
06/02/1998US5760018 Treatment of pain, inflammation, migraine, emesis
06/02/1998US5760009 Anticholesterol agents
06/02/1998US5759996 Reduce bone resorption, angiogenesis, and restenosis
06/02/1998US5759994 Antithrombin peptide for cardiovascular disorders
06/02/1998US5759775 Hybridization; amplification
06/02/1998US5759580 Hypotensive agents
06/02/1998US5759548 Using plant extract
06/02/1998US5759543 Application of a cell culture of a fusarium fungus strain producer for medical uses
05/1998
05/28/1998WO1998022606A1 Recombinant bicistron adenovirus for treating pathological conditions linked with dyslipoproteinemia
05/28/1998WO1998022500A2 Modulation of interactions between myosin and integrins
05/28/1998WO1998022483A1 New phosphonates, process for preparing the same and medicaments
05/28/1998WO1998022479A1 Pharmaceutical formulations
05/28/1998WO1998022465A1 A1 adenosine receptor antagonists
05/28/1998WO1998022464A1 Xanthines and their therapeutic use
05/28/1998WO1998022460A1 Bicyclic aryl carboxamides and their therapeutic use
05/28/1998WO1998022459A1 Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine
05/28/1998WO1998022457A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
05/28/1998WO1998022436A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors
05/28/1998WO1998022423A1 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses
05/28/1998WO1998022418A1 Substituted phenols and thiophenols useful as antioxidant agents
05/28/1998WO1998022138A1 Method for treating symptoms of diabetes
05/28/1998WO1998022133A1 NOVEL FabD
05/28/1998WO1998022126A1 USE OF CONOTOXIN PEPTIDES ImI AND MII AS CARDIOVASCULAR AGENTS
05/28/1998WO1998022113A1 Methods of prevention and treatment of ischemic damage
05/28/1998WO1998022109A1 Triaryl substituted imidazoles as glucagon antagonists
05/28/1998WO1998022108A1 Triaryl substituted imidazoles and methods of use
05/28/1998WO1998022099A2 New use of creatine
05/28/1998WO1998021957A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
05/28/1998WO1998016551A3 Variants of vascular endothelial cell growth factor having antagonistic properties
05/28/1998WO1998016503A3 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
05/28/1998DE19649460A1 Neue substituierte Pyrazolderivate New substituted pyrazole derivatives
05/28/1998DE19648793A1 Neue Benzamide und deren Anwendung New benzamides and their application
05/28/1998CA2633660A1 Method for treating symptoms of diabetes
05/28/1998CA2271963A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
05/28/1998CA2271941A1 Triaryl substituted imidazoles and methods of use
05/28/1998CA2271893A1 Triaryl substituted imidazoles as glucagon antagonists
05/28/1998CA2271814A1 New phosphonates, process for preparing the same and medicaments
05/28/1998CA2271769A1 Use of conotoxin peptides imi and mii as cardiovascular agents
05/28/1998CA2271767A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
05/28/1998CA2271437A1 Recombinant bicistron adenovirus for treating pathological conditions linked with dyslipoproteinemia
05/28/1998CA2271273A1 Methods of prevention and treatment of ischemic damage
05/28/1998CA2268770A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors
05/28/1998CA2268041A1 Xanthines and their therapeutic use
05/28/1998CA2268037A1 Bicyclic aryl carboxamides and their therapeutic use
05/27/1998EP0843999A1 Use of estrogen agonists/antagonists for the manufacture of a medicament in the treatment of atherosclerosis independent of a lipid lowering effect
05/27/1998EP0843678A1 1,9-diazabicyclo 4.3.0]nona-3,8-diene derivatives
05/27/1998EP0843674A1 Lubeluzole n-oxide
05/27/1998EP0843671A1 Heterocyclic compounds and pharmaceutical compositions containing them
05/27/1998EP0843670A1 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4-(naphthalen-1-yl)piperazine derivatives, preparation thereof and therapeutical use thereof
05/27/1998EP0843556A1 Glyceryl poly(meth)acrylate type gel based pharmaceutical compositions
05/27/1998EP0843551A1 Endothelin receptor antagonists
05/27/1998CN1183099A Pyrido (2, 3 -d) pyrimidines for inbibiting protein tyrosine kinase mediated cellular proliferation
05/27/1998CN1183096A Optically active thiazolidinone derivatives
05/27/1998CN1183043A Preparation and use of sulfated oligosaccharides
05/27/1998CN1183041A Indazolecarboxamides
05/27/1998CN1183039A Novel collagen formulations
1 ... 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 ... 1595